Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 6, 2011, Pages 620-626

  Ratkevicius, A ^a   Joyson, A ^a   Selmer, I ^b   Dhanani, T ^b   Grierson, C ^b   Tommasi, A M ^b   DeVries, A ^b   Rauchhaus, P ^b   Crowther, D ^b   Alesci, S ^c   Yaworsky, P ^c   Gilbert, F ^a   W Redpath, T ^a   Brady, J ^b   Fearon, K C H ^d   Reid, D M ^a   Greig, C A ^d   Wackerhage, H ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Translational Medicine Research Collaboration Core Laboratory   (United Kingdom)

^c PFIZER INC   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Myostatin; Sarcopenia

Indexed keywords

FOLLISTATIN; FOLLISTATIN RELATED PROTEIN; INTERLEUKIN 6; MYOSTATIN; PROTEIN; SOMATOMEDIN C; TESTOSTERONE; WFIKKNRP PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD; HUMAN; MALE; MUSCLE ATROPHY; MUSCLE CONTRACTION;

ADULT; AGED; FOLLISTATIN; FOLLISTATIN-RELATED PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MALE; MUSCLE CONTRACTION; MYOSTATIN; PROTEINS; SARCOPENIA; TESTOSTERONE;

EID: 80051511849     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr025     Document Type: Article

References (42)

1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S-991S. (Pubitemid 27209486)
2. Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull. 2010;95:139-159.
3. Clark BC, Manini TM. Sarcopenia ≠ dynapenia. J Gerontol A Biol Sci Med Sci. 2008;63:829-834.
4. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Med Sci. 2002;57:M326-M332. (Pubitemid 34464974)
5. Ploutz-Snyder LL, Manini T, Ploutz-Snyder RJ, Wolf DA. Functionally relevant thresholds of quadriceps femoris strength. J Gerontol A Biol Sci. 2002;57:B144-B152. (Pubitemid 34263291)
6. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560. (Pubitemid 29081310)
7. Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2004;52:1121-1129. (Pubitemid 38869071)
8. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006;84:475-482. (Pubitemid 44713395)
9. Ruiz J.R, Sui X, Lobelo F, et al. Association between muscular strength and mortality in men: prospective cohort study. BMJ. 2008;337:92-95. (Pubitemid 352017229)
10. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009;13:724-728.
11. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-763. (Pubitemid 28183275)
12. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851-1860. (Pubitemid 37310367)
13. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;9:412-423.
14. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84:275-294. (Pubitemid 18087270)
15. Cuthbertson D, Smith K, Babraj J, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005;19:422-424. (Pubitemid 40316537)
16. Rasmussen BB, Fujita S, Wolfe RR, et al. Insulin resistance of muscle protein metabolism in aging. FASEB J. 2006;20:768-769. (Pubitemid 46671209)
17. Kumar V, Selby A, Rankin D, et al. Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol. 2009;587:211-217.
18. Wilkes EA, Selby AL, Atherton PJ, et al. Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia. Am J Clin Nutr. 2009;90:1343-1350.
19. Carlson ME, Suetta C, Conboy MJ, et al. Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol Med. 2009;1:381-391.
20. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61-86.
21. Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;350:2682-2688. (Pubitemid 38788003)
22. Zimmers TA, Davies MV, Koniaris LG, et al. Induction of cachexia in mice by systemically administered myostatin. Science. 2002;296:1486-1488. (Pubitemid 34553097)
23. Siriett V, Platt L, Salerno MS, Ling N, Kambadur R, Sharma M. Prolonged absence of myostatin reduces sarcopenia. J Cell Physiol. 2006;209:866-873. (Pubitemid 44665708)
24. Lakshman KM, Bhasin S, Corcoran C, et al. Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol. 2009;302:26-32.
25. Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by GASP-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol. 2003;17:1144-1154.
26. Hill JJ, Davies MV, Pearson AA, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem. 2002;277:40735-40741. (Pubitemid 35215657)
27. Lee SJ. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One. 2007;e789:1-7.
28. Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009;64:1183-1189.
29. Payette H, Roubenoff R, Jacques PF, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc. 2003;51:1237-12343.
30. Hameed M, Harridge SD, Goldspink G. Sarcopenia and hypertrophy: a role for insulin-like growth factor-1 in aged muscle? Exerc Sport Sci Rev. 2002;30:15-19. (Pubitemid 34272898)
31. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ III, Khosla S. A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res. 2004;19:1075-1083. (Pubitemid 41110558)
32. Petrella JK, Kim JS, Cross JM, Kosek DJ, Bamman MM. Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women. Am J Physiol Endocrinol Metab. 2006;291:E937-E946.
33. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26:833-876. (Pubitemid 41428540)
34. Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol. 1998;275:E864-E871.
35. Babault N, Desbrosses K, Fabre MS, Michaut A, Pousson M. Neuromuscular fatigue development during maximal concentric and isometric knee extensions. J Appl Physiol. 2006;100:780-785. (Pubitemid 43671530)
36. Greig CA, Young A, Skelton DA, Pippet E, Butler FM, Mahmud SM. Exercise studies with elderly volunteers. Age Ageing. 1994;23:185-189. (Pubitemid 24158285)
37. Streckis V, Skurvydas A, Ratkevicius A. Children are more susceptible to central fatigue than adults. Muscle Nerve. 2007;36:357-363. (Pubitemid 47326015)
38. Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2003;51:323-330. (Pubitemid 36348893)
39. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A. 1998;95:14938-14943. (Pubitemid 29003735)
40. Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001;3:1009-1013. (Pubitemid 34428746)
41. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Med Sci. 2002;57:M772-M777. (Pubitemid 35470952)
42. Wagner KR, Fleckenstein JL, Amato AA, et al. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008;63:561-571.